nanodrop
Forecast New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $10,000 to $25,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Points of contact
-
- CBER Acquisition Liaison cberacquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is procuring a REVOLVE R4 microscope to replace existing brightfield-only imaging equipment in the Kemaladewi Laboratory, Gene Therapy Immunology Branch, with an estimated solicitation release on June 1, 2027 and award on September 1, 2027. The instrument will provide both upright and inverted imaging with brightfield and multi-channel fluorescence capabilities for characterization and evaluation of gene therapy products, reducing the need for multiple microscopes and expanding imaging capacity for research and regulatory science activities.
The estimated award value ranges from $10,000 to $25,000. Place of performance is the Kemaladewi Laboratory within the Gene Therapy Immunology Branch. Questions should be directed to the FDA's Center for Drug Evaluation and Research acquisitions mailbox at cberacquisitions@fda.hhs.gov.
Forecast text
The REVOLVE R4 microscope provides both upright and inverted imaging in a single instrument, enabling versatile brightfield and multi-channel fluorescence imaging of cultured cells and tissue specimens used in the characterization and evaluation of gene therapy products while reducing the need for multiple microscopes. It will replace a brightfield-only microscope currently housed in the Kemaladewi Laboratory, Gene Therapy Immunology Branch (GTIB), significantly expanding imaging capabilities and ensuring continued support for research and regulatory science activities.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast